Alex Chang

Medicine & Life Sciences

1. Non-Small Cell Lung Carcinoma 100%
2. Paclitaxel 45%
3. Breast Neoplasms 44%
4. Etoposide 39%
5. Drug Therapy 37%
6. Carboplatin 35%
7. Gefitinib 31%
8. Cisplatin 28%
9. Lung Neoplasms 27%
10. Ifosfamide 26%
11. Survival 25%
12. Neoplasms 25%
13. ErbB Receptors 23%
14. Therapeutics 22%
15. Doxorubicin 22%
16. Vinorelbine 21%
17. Interferons 20%
18. Nasopharyngeal Carcinoma 19%
19. Neoplasm Metastasis 18%
20. Singapore 17%
21. acetyltanshinone IIA 16%
22. Placebos 15%
23. Fluorouracil 15%
24. Small Cell Lung Carcinoma 15%
25. Mutation 14%
26. 4(3H)-pyrimidinone 14%
27. spirogermanium 14%
28. Carcinoma 13%
29. Ondansetron 13%
30. Vomiting 13%
31. Mitolactol 13%
32. Echinomycin 12%
33. Mitomycin 12%
34. Dasatinib 12%
35. Lung 12%
36. Hepatocellular Carcinoma 12%
37. Aclarubicin 12%
38. Tamoxifen 11%
39. Pharmacokinetics 11%
40. Radiotherapy 11%
41. Vincristine 11%
42. Radiation 10%
43. liposomal doxorubicin 10%
44. anthracene 10%
45. Appointments and Schedules 9%
46. Topotecan 9%
47. Nausea 9%
48. Growth 9%
49. Prostate 8%
50. Leukopenia 8%